Log in to save to my catalogue

METTL14 aggravates podocyte injury and glomerulopathy progression through N 6 -methyladenosine-depen...

METTL14 aggravates podocyte injury and glomerulopathy progression through N 6 -methyladenosine-depen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_34580283

METTL14 aggravates podocyte injury and glomerulopathy progression through N 6 -methyladenosine-dependent downregulating of Sirt1

About this item

Full title

METTL14 aggravates podocyte injury and glomerulopathy progression through N 6 -methyladenosine-dependent downregulating of Sirt1

Publisher

England

Journal title

Cell death & disease, 2021-09, Vol.12 (10), p.881

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

Podocytes are known to play a determining role in the progression of proteinuric kidney disease. N
-methyladenosine (m6A), as the most abundant chemical modification in eukaryotic mRNA, has been reported to participate in various pathological processes. However, its role in podocyte injury remains unclear. In this study, we observed the elevated...

Alternative Titles

Full title

METTL14 aggravates podocyte injury and glomerulopathy progression through N 6 -methyladenosine-dependent downregulating of Sirt1

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_34580283

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_34580283

Other Identifiers

E-ISSN

2041-4889

DOI

10.1038/s41419-021-04156-y

How to access this item